1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NJCCR Request for Applications 2027 is sponsored by New Jersey Commission on Cancer Research (NJCCR). The New Jersey Commission on Cancer Research (NJCCR) funds significant and original research related to cancer in New Jersey, focusing on causes, prevention, treatment, and improving health disparities. This RFA is for the 2027 grant opportunities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
## **New Jersey Commission on Cancer Research (NJCCR)** ## **Fight Cancer Through Research** Cancer is the 2nd leading cause of death in New Jersey. Every donation counts. The New Jersey Commission on Cancer Research (NJCCR) was established on January 17, 1983, with the passage of the “Cancer Research Act” by the New Jersey State Legislature.
NJCCR promotes significant and original research related to Cancer in New Jersey. The NJCCR functions as an independent body and serves as an important resource to providers and consumers of cancer services in the State.
The **mission** of the NJCCR is to ensure that the citizens of New Jersey receive the fullest benefit of our nation’s fight against cancer through the promotion and funding of research into the causes, prevention, and treatment of cancer. In pursuit of this mission, NJCCR funds cancer research focused on fostering fundamental creative discoveries, innovation, and improving health disparities in New Jersey.
NJCCR’s primary objectives include: * Review and authorize approved cancer research projects; * Apportion all available funds to qualifying research institutions to finance approved research projects and necessary institutional support services; * Ensure that funds appropriated to approved research projects are not diverted to any other use; * Take steps necessary to encourage the development within the State of research projects on: * pain management and palliative care for persons diagnosed with cancer and * Provide the Governor and the Legislature with an Annual Report describing the state of the commission’s activities and the results of its funded research efforts.
Each year the NJCCR receives a state appropriation to facilitate its mission of advancing cancer research in New Jersey. Additional funding for research grants comes from donations made on New Jersey State Individual Tax forms line #71 and proceeds from the specialty Conquer Cancer license plates.
### **2027 Grant Opportunities** NJCCR Request for Application (RFA) for the Fellowship Training Program RFA - NJCCR Request for Applications 2027 Pre-award Technical Assistance slides for RFA 2027 Supplemental NJCCR Bridge Grant Guidelines for RFA 2027 Email NJCCR@doh. nj.
gov for more information **Public Meeting Calendar** In compliance with the Open Public Meeting Act (NJSA 10:4-6 – 10:4-21) the following meetings are scheduled for the NJCCR: **Date/Time****Location** Tuesday, January 20, 2026 9:00 AM – 10:00 AM Videoconference via MS Teams Wednesday, April 22, 2026 9:00 AM – 10:00 AM Videoconference via MS Teams 9:00 AM – 10:30 AM Videoconference via MS Teams 9:00 AM – 10:00 AM CLOSED EXECUTIVE SESSION **Donate to Cancer Research** **General Cancer Research Fund** Donating to the general cancer research fund supports cancer research grants administered by NJCCR.
**Donate to Specific Cancer Research Funds** ****Commission Members, Pediatric Advisory Group, and NJCCR Staff**** NJCCR membership consists of 11 members who are volunteers appointed by the Governor. New Jersey residents wishing to be considered for appointment may submit his/her name to the Governor’s Office of Appointments. Information on how to apply can be found at: https://www.
nj. gov/governor/admin/bca. Kenneth R.
Adler**Morristown Medical Center**Kathleen Scotto**Rutgers School of Biomedical and Health Sciences **Generosa Grana**M. D.
Anderson Cancer Center at Cooper**Wendy Budin**Rutgers School of Nursing **Li Li**Novartis Pharmaceuticals Corporation**Shawna Hudson**Rutgers Robert Wood Johnson Medical School **Christine Schell**New Jersey Department of Environmental Protection**Uta Steinhauser (Commissioner’s Designee)**New Jersey Department of Health **Michele L.
Donato**Hackensack University Medical Center**Jane Flint**Princeton University **Pediatric Advisory Group** Rutgers Cancer Institute of New Jersey**(Co-Chair) Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey**Daniel Notterman** Robert Wood Johnson University Hospital Hackensack University Medical Center**Ahmed-Rafat** Cooper Medical School of Rowan University **Lisa H.
Cummings**Executive Director**Candido Africa**Program Management Officer **Amir Bhochhibhoya**Program Management Officer**Anita Madavane**Grants Management Officer **Jitendra Jagasia**Grants Management Officer New Jersey Commission on Cancer Research PO Box 364, 25 South Stockton Street, 2 nd Floor Rear **Email:**NJCCR@doh. nj. gov
According to the current listing, eligibility includes: Qualifying research institutions in New Jersey undertaking cancer research projects. Confirm the full requirements in the official notice before applying.
NJCCR Request for Applications 2027 is funded by New Jersey Commission on Cancer Research (NJCCR). Verify program details on the funder's official page before applying.
This opportunity targets applicants in New Jersey. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NJDOL's FY2027 cycle runs UPSKILL, PACE, NJBUILD WMIC and GAINS with mandatory Letters of Intent in October. The $7M UPSKILL Round 1 LOI gate shut on September 23 — and the application deadline is still open.
Read articleRFA-RM-27-008 funds one or two U24 centers to sequence 6,000-10,000 pediatric samples a year for Gabriella Miller Kids First. Due January 8, 2027. Who can compete.
Read articleProp. 38, the $8.4 billion immunology research bond, led 56% to 44% the morning after the November 3, 2026 election. Here is what the statute says about who can get the grant money, the 20% indirect cap, and the timeline.
Read article